DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: Replicated evidence from two mild cognitive impairment cohorts

Epigenomics

Volumn 7, Issue 4, 2015, Pages 533-537

  Chouliaras, Leonidas ^a   Kenis, Gunter ^a   Visser, Pieter Jelle ^a,b   Scheltens, Philip ^b   Tsolaki, Magda ^c   Jones, Roy W ^d   Kehoe, Patrick G ^e   Graff, Caroline ^f   Girtler, Nicola G ^g   Wallin, Åsa K ^h   Rikkert, Marcel Olde ⁱ   Spiru, Luiza ^j   Elias Sonnenschein, Lyzel S ^a   Ramakers, Inez H G ^a   Pishva, Ehsan ^a   Os, Jim Van ^a   Steinbusch, Harry W ^a   Verhey, Frans R J ^a   Van Den Hove, Daniel L A ^a   Rutten, Bart P F ^a,k  

^a European Graduate School of Neuroscience   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Research Institute for the Care of Older People (RICE)   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY OF GENOA   (Italy)

^h LUND UNIVERSITY   (Sweden)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^k MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

aging; DNA methylation; DNMT3A; epigenetics; MCI; mild cognitive impairment; SNP

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DNA METHYLATION; GENE CONTROL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; CASE CONTROL STUDY; COGNITION; FEMALE; GENETICS; MALE; MIDDLE AGED;

AGED; CASE-CONTROL STUDIES; COGNITION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84933505719     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.22     Document Type: Article

References (20)

1. Chouliaras L, Rutten BP, Kenis G et al. Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog. Neurobiol. 90(4), 498-510 (2010).
2. Day JJ, Sweatt JD. DNA methylation and memory formation. Nat. Neurosci. 13(11), 1319-1323 (2010).
3. Chouliaras L, Mastroeni D, Delvaux E et al. Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol. Aging 34(9), 2091-2099 (2013).
4. Daniilidou M, Koutroumani M, Tsolaki M. Epigenetic mechanisms in Alzheimer's disease. Curr. Med. Chem. 18(12), 1751-1756 (2011).
5. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 14(10), R115 (2013).
6. Bi XH, Zhao HL, Zhang ZX, Zhang JW. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiol. Aging 30(10), 1601-1607 (2009).
7. Coppede F, Zitarosa MT, Migheli F et al. DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. Curr. Alzheimer Res. 9(5), 550-554 (2012).
8. Pezzi JC, Ens CM, Borba EM et al. DNA methyltransferase haplotype is associated with Alzheimer's disease. Neurosci. Lett. 579, 70-74 (2014).
9. Morgan AR, Hamilton G, Turic D et al. Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B(6), 727-731 (2008).
10. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 67(7), 1201-1207 (2006).
11. Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet. Epidemiol. 31(4), 358-362 (2007).
12. Pishva E, Drukker M, Viechtbauer W et al. Epigenetic genes and emotional reactivity to daily life events: a multistep gene-environment interaction study. PLoS ONE 9(6), e100935 (2014).
13. Sherry ST, Ward MH, Kholodov M et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29(1), 308-311 (2001).
14. Chen T, Ueda Y, Xie S, Li E. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J.Biol. Chem. 277(41), 38746-38754 (2002).
15. Oliveira AM, Hemstedt TJ, Bading H. Rescue of agingassociated decline in Dnmt3a2 expression restores cognitive abilities. Nat. Neurosci. 15(8), 1111-1113 (2012).
16. Feng J, Zhou Y, Campbell SL et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13(4), 423-430 (2010).
17. Wu H, Coskun V, Tao J et al. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 329(5990), 444-448 (2010).
18. Guo JU, Su Y, Shin JH et al. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat. Neurosci. 17(2), 215-222 (2013).
19. Chouliaras L, Van Den Hove DL, Kenis G et al. Caloric restriction attenuates age-related changes of DNA methyltransferase 3a in mouse hippocampus. Brain Behav. Immun. 25(4), 616-623 (2011).
20. Haggarty P, Hoad G, Harris SE et al. Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. PLoS ONE 5(6), e11329 (2010).